Pharming to present at Bio-Europe 2009

Health and Fitness Health and Fitness

Mon, November 16, 2009

[ Mon, Nov 16th 2009 ] - Market Wire

Protox reports 2009 third quarter results

[ Mon, Nov 16th 2009 ] - Market Wire

China INSOnline Reports 27% Gain in First Quarter Net Income on 6% Decline in Revenues

Sun, November 15, 2009

[ Sun, Nov 15th 2009 ] - Market Wire

The Medicines Company's Full Analysis of CHAMPION .. or Significantly Improves Patient Outcomes Follow

Fri, November 13, 2009

[ Fri, Nov 13th 2009 ] - Market Wire

BioSyntech announces second quarter fiscal 2010 financial results

[ Fri, Nov 13th 2009 ] - Market Wire

MedaSorb Technologies Corporation Provides Clinical Update

[ Fri, Nov 13th 2009 ] - Market Wire

MedaSorb Technologies Corporation Announces Q3 2009 Results and Files Form 10-Q, Quarterly Report

[ Fri, Nov 13th 2009 ] - Market Wire

Quest PharmaTech Announces the Passing of One of its Directors

[ Fri, Nov 13th 2009 ] - Market Wire

SemBioSys announces third quarter 2009 financial and operational results

[ Fri, Nov 13th 2009 ] - Market Wire

San West Inc. Reports Third-Quarter 2009 Results

[ Fri, Nov 13th 2009 ] - Market Wire

Agennix AG to Present at Lazard Capital Markets 6th Annual Healthcare Conference

Thu, November 12, 2009

[ Thu, Nov 12th 2009 ] - Market Wire

The Edwards Lifesciences Fund to Grant $4.6 Million to Nonprofit Organizations in 2009

[ Thu, Nov 12th 2009 ] - Market Wire

International Drug & Explosives Detection Firm ID .. Retail Marketing Progress Through Earthbound, LLC

[ Thu, Nov 12th 2009 ] - Market Wire

Horizon Health International Receives eBay Vendor Status as Part of its Product Awareness Campaign

[ Thu, Nov 12th 2009 ] - Market Wire

(NYSE Amex: DXR) Daxor Corporation Announces Third Quarter 2009 Earnings

[ Thu, Nov 12th 2009 ] - Market Wire

Spectral announces third quarter 2009 results

[ Thu, Nov 12th 2009 ] - Market Wire

Medical Facilities Corporation Reports 2009 Third Quarter Financial Results

[ Thu, Nov 12th 2009 ] - Market Wire

Reflect Scientific Enters Cooperative Marketing A .. iner for Patented Refrigerated Truck Cooling Syst

Wed, November 11, 2009

[ Wed, Nov 11th 2009 ] - Market Wire

Nuvo research provides WF10 licensing and development update

[ Wed, Nov 11th 2009 ] - Market Wire

Lodgement of Information Memorandum With ASIC

[ Wed, Nov 11th 2009 ] - Market Wire

Isotechnika Pharma reports third quarter 2009 financial results

[ Wed, Nov 11th 2009 ] - Market Wire

Unilife Announces Appointment of New Independent Director

[ Wed, Nov 11th 2009 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference

[ Wed, Nov 11th 2009 ] - Market Wire

Premium Brands Holdings Corporation Announces Intention to Make Normal Course Issuer Bid

[ Wed, Nov 11th 2009 ] - Market Wire

TSO3 announces financial results for Q3 2009 and updates on negotiations with 3M

Tue, November 10, 2009

[ Tue, Nov 10th 2009 ] - Market Wire

HearUSA Reports Third Quarter 2009 Results

[ Tue, Nov 10th 2009 ] - Market Wire

Unilife Receives A$28.7 Million in SPP Applications

[ Tue, Nov 10th 2009 ] - Market Wire

Corcept Therapeutics Announces Recent Highlights and Third Quarter 2009 Financial Results

[ Tue, Nov 10th 2009 ] - Market Wire

Meridian Medical Inc. Expands Distribution in Florida

[ Tue, Nov 10th 2009 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Credit Suisse 18th Annual Global Healthcare Conference

[ Tue, Nov 10th 2009 ] - Market Wire

Dynavax to Acquire Symphony Dynamo, Inc., Including $20 Million in Unrestricted Cash

[ Tue, Nov 10th 2009 ] - Market Wire

Appointment of Hans Mader to the Sernova Business Advisory Board

Mon, November 9, 2009

[ Mon, Nov 09th 2009 ] - Market Wire

2009 third quarter financial results

[ Mon, Nov 09th 2009 ] - Market Wire

Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials

[ Mon, Nov 09th 2009 ] - Market Wire

Allana Resources Announces Closing of $2.0 Million Strategic Investment

[ Mon, Nov 09th 2009 ] - Market Wire

Adeona Launches CopperProof Test Panel

[ Mon, Nov 09th 2009 ] - Market Wire

SciClone Reports Financial Results and Provides C .. nd Pipeline Updates for the Third Quarter of 2009

[ Mon, Nov 09th 2009 ] - Market Wire

Cypress Bioscience Announces Third Quarter 2009 Financial Results

[ Mon, Nov 09th 2009 ] - Market Wire

Syneron Reports Third Quarter 2009 Financial Results

Fri, November 6, 2009

[ Fri, Nov 06th 2009 ] - Market Wire

Cardiome to Release Third Quarter Results

[ Fri, Nov 06th 2009 ] - Market Wire

Hypertension Diagnostics Announces First Quarter Fiscal Year 2010 Results

[ Fri, Nov 06th 2009 ] - Market Wire

Stellar Pharmaceuticals' Q3-2009 Financial Result .. rked by Strong Growth and Continued Profitability

[ Fri, Nov 06th 2009 ] - Market Wire

Oncolytics Biotech(R) Inc. Collaborators Present .. e II Sarcoma Trial Results at CTOS Annual Meeting

[ Fri, Nov 06th 2009 ] - Market Wire

First Transcatheter Valve Cases in Japan Performed With Edwards SAPIEN Valve

[ Fri, Nov 06th 2009 ] - Market Wire

Metro One Development Prepares for Ad Sales

[ Fri, Nov 06th 2009 ] - Market Wire

Agennix AG Shares Begin Trading on Frankfurt Stock Exchange

Thu, November 5, 2009

[ Thu, Nov 05th 2009 ] - Market Wire

Centric Health reports solid 2009 third quarter financial results

[ Thu, Nov 05th 2009 ] - Market Wire

Theravance and Astellas Announce the Commercial L .. of VIBATIV(TM) (telavancin) in the United States

[ Thu, Nov 05th 2009 ] - Market Wire

DIAGNOS Announces the Sale of the Harricana North Property to North American Palladium Ltd

[ Thu, Nov 05th 2009 ] - Market Wire

Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results

Wed, November 4, 2009

[ Wed, Nov 04th 2009 ] - Market Wire

Given Imaging Reports Third Quarter 2009 Results

[ Wed, Nov 04th 2009 ] - Market Wire

Depression Treatments Reviewed by NeuroInvestment

[ Wed, Nov 04th 2009 ] - Market Wire

Meridian Medical Sales Distribution Expands in Key East Coast Markets

[ Wed, Nov 04th 2009 ] - Market Wire

Remedent to Present FirstFit, a Revolutionary Sol .. owns, at the Den-Mat Education Destination Semina

[ Wed, Nov 04th 2009 ] - Market Wire

ImmuCell Announces Financial Results for Third Quarter of 2009

[ Wed, Nov 04th 2009 ] - Market Wire

&;AElig;terna Zentaris to Announce Third Quarter .. ancial and Operating Results on November 11, 2009

[ Wed, Nov 04th 2009 ] - Market Wire

Cipher reports Q3 2009 financial results

Tue, November 3, 2009

[ Tue, Nov 03rd 2009 ] - Market Wire

Cipher appoints Dr. William Claypool to Board of Directors

[ Tue, Nov 03rd 2009 ] - Market Wire

Atrium Innovations Joins the Council for Responsible Nutrition

[ Tue, Nov 03rd 2009 ] - Market Wire

Optigenex Inc. Announces New Business to Business .. rketing and Manufacturing Companies in the Skin C

[ Tue, Nov 03rd 2009 ] - Market Wire

Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program

[ Tue, Nov 03rd 2009 ] - Market Wire

MDS Inc. and Danaher Corporation Receive Second R .. .S. Federal Trade Commission for MDS Analytical T

[ Tue, Nov 03rd 2009 ] - Market Wire

SciClone Pharmaceuticals to Present at Two November Investor Conferences

[ Tue, Nov 03rd 2009 ] - Market Wire

Reflect Scientific Consolidates Cryometrix Product Line to Montana Facility

Mon, November 2, 2009

[ Mon, Nov 02nd 2009 ] - Market Wire

Bennett Environmental Inc. Announces Extension of Previously Announced Project

[ Mon, Nov 02nd 2009 ] - Market Wire

AVI BioPharma Announces Third Quarter 2009 Financial Results Conference Call

[ Mon, Nov 02nd 2009 ] - Market Wire

Adeona Receives IRB Approval to Initiate Clinical .. -Daily Oral Zinthionein ZC in Alzheimer's Disease

[ Mon, Nov 02nd 2009 ] - Market Wire

InternetArray Launches PremierGoldTraders.com

[ Mon, Nov 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference

[ Mon, Nov 02nd 2009 ] - Market Wire

Sernova Closes First Tranche of Private Placement .. nt of Dr. Annemarie Moseley to Board of Directors

[ Mon, Nov 02nd 2009 ] - Market Wire

Flutiform EU Clinical Trial Successfully Completed

Sun, November 1, 2009

[ Sun, Nov 01st 2009 ] - Market Wire

Human Genome Sciences and GlaxoSmithKline Announc .. of Two Phase 3 Trials of BENLYSTA(TM) in Systemic

Fri, October 30, 2009

[ Fri, Oct 30th 2009 ] - Market Wire

San West, Inc. Postpones Upcoming Forward Stock Split

[ Fri, Oct 30th 2009 ] - Market Wire

Novo Nordisk A/S: Novo Nordisk A/S: Director/PDMR Shareholding

[ Fri, Oct 30th 2009 ] - Market Wire

Sierra Geothermal Awarded US$10 Million of DOE Grants

[ Fri, Oct 30th 2009 ] - Market Wire

MMR Information Systems' Medical Advisor Dr. Arno .. W. Klein Authors Guide on Personal Health Records

[ Fri, Oct 30th 2009 ] - Market Wire

Cypress Bioscience, Inc. to Present at Oppenheimer 20th Annual Healthcare Conference

[ Fri, Oct 30th 2009 ] - Market Wire

Oncolytics Biotech(R) Inc. Collaborators to Prese .. e II Sarcoma Trial Results at CTOS Annual Meeting

[ Fri, Oct 30th 2009 ] - Market Wire

SemBioSys enters in non-dilutive financing plan of arrangement

Thu, October 29, 2009

[ Thu, Oct 29th 2009 ] - Market Wire

Midland Starts First Exploration Program With Nor .. h American Palladium on the Laflamme Gold Project

[ Thu, Oct 29th 2009 ] - Market Wire

Gamma Pharmaceuticals Secures Registered Trademark Protection in China

[ Thu, Oct 29th 2009 ] - Market Wire

MDRNA to Present Data on Tumor Reduction at Cancer Therapy Conference

[ Thu, Oct 29th 2009 ] - Market Wire

Reflect Scientific Wins "Most Innovative Gre .. t" Award for Its Patented Cooling Technology

[ Thu, Oct 29th 2009 ] - Market Wire

Protox presents Phase 2 BPH data at the World Congress of the Societe Internationale d';Urologie

[ Thu, Oct 29th 2009 ] - Market Wire

Hackett's Department Stores: Seaway Valley Capita .. olsters Fashion Lines With Addition of Point Zero

[ Thu, Oct 29th 2009 ] - Market Wire

Novo Nordisk A/S: 3rd Quarter Results

Wed, October 28, 2009

[ Wed, Oct 28th 2009 ] - Market Wire

TomoTherapy Announces Third Quarter Financial Results

[ Wed, Oct 28th 2009 ] - Market Wire

Meridian Medical Inc. (MMI) Expands Distribution on the West Coast

[ Wed, Oct 28th 2009 ] - Market Wire

MMR Information Systems' MMRPro Seen as Solution to Doctors' Difficulties With EMR Systems

[ Wed, Oct 28th 2009 ] - Market Wire

Eurand Completes Public Offering, Including Exerc .. -Allotment Option, for Total Net Proceeds of Appr

[ Wed, Oct 28th 2009 ] - Market Wire

The Medicines Company Reports Third Quarter 2009 Financial Results

[ Wed, Oct 28th 2009 ] - Market Wire

SciClone Announces Corporate Restructuring and Workforce Reduction

Tue, October 27, 2009

[ Tue, Oct 27th 2009 ] - Market Wire

Sun Healthcare Group, Inc. Reports Third-Quarter Earnings and Normalized EPS of $0.25

[ Tue, Oct 27th 2009 ] - Market Wire

Unilife to Market Its Ready-to-Fill Syringes Under Unifill(TM) Brand

[ Tue, Oct 27th 2009 ] - Market Wire

GlaxoSmithKline and Theravance commence Phase III .. e to develop a next-generation treatment for COPD

[ Tue, Oct 27th 2009 ] - Market Wire

QLT Announces Share Repurchase Program

[ Tue, Oct 27th 2009 ] - Market Wire

BIOLASE to Present at the AeA Classic Financial Conference in San Diego, CA

[ Tue, Oct 27th 2009 ] - Market Wire

QLT announces third quarter results for 2009

Mon, October 26, 2009

[ Mon, Oct 26th 2009 ] - Market Wire

Pharming to present at Bio-Europe 2009

[ Mon, Oct 26th 2009 ] - Market Wire

Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting

[ Mon, Oct 26th 2009 ] - Market Wire

Stellar Pharmaceuticals Signs Licensing Agreement .. istribution And Sale of Uracyst(R) in South Korea

[ Mon, Oct 26th 2009 ] - Market Wire

AVI BioPharma Presents Updated Safety Data From O .. -4658 at 7th Annual Action Duchenne International

[ Mon, Oct 26th 2009 ] - Market Wire

Oncolytics Biotech(R) Inc. Announces Results of First Warrant Expiry Date Acceleration Program

[ Mon, Oct 26th 2009 ] - Market Wire

BIOLASE Names Gregory D. Waller to Board of Directors

Sun, October 25, 2009

[ Sun, Oct 25th 2009 ] - Market Wire

San West, Inc. Announces 5-for-1 Forward Split Record Date Set for Close of Business October 26th

Fri, October 23, 2009

[ Fri, Oct 23rd 2009 ] - Market Wire

&;AElig;terna Zentaris Receives US$5.5 Million from Institutional Investors

[ Fri, Oct 23rd 2009 ] - Market Wire

Unilife Secures US$5.2m in Pennsylvania Job Creation Program Funds to Fuel Corporate Expansion

[ Fri, Oct 23rd 2009 ] - Market Wire

Unilife Secures US$5.2m in Pennsylvania Job Creation Program Funds to Fuel Corporate Expansion

[ Fri, Oct 23rd 2009 ] - Market Wire

Unilife Secures US$5.2m in Pennsylvania Job Creation Program Funds to Fuel Corporate Expansion

[ Fri, Oct 23rd 2009 ] - Market Wire

Health Canada approves IMRISNV and IMRIScardio

[ Fri, Oct 23rd 2009 ] - Market Wire

MoneyTV; BioTime, Inc.; Cord Blood America, Inc.; .. en Baron Report; Brewer Investment Group; Skyline

Thu, October 22, 2009

[ Thu, Oct 22nd 2009 ] - Market Wire

MMR Information Systems, Inc.: MMR Information Sy .. ysicians With Kodak in Attendance November 4-5 at

[ Thu, Oct 22nd 2009 ] - Market Wire

Pharming recombinant human C1 inhibitor: Results .. erfusion model confirm potential for new indicati

[ Thu, Oct 22nd 2009 ] - Market Wire

Atrium Innovations to Hold 2009 Third Quarter Fin .. ults Conference Call and Webcast on November 11th

[ Thu, Oct 22nd 2009 ] - Market Wire

Eurand N.V.: Eurand Announces Pricing of Offering of Ordinary Shares

[ Thu, Oct 22nd 2009 ] - Market Wire

SemBioSys enters into commercialization and supply agreement for plant-made chymosin protein

[ Thu, Oct 22nd 2009 ] - Market Wire

Digirad: Digirad Corporation Reports Third Quarter 2009 Financial Results

Wed, October 21, 2009

[ Wed, Oct 21st 2009 ] - Market Wire

Meridian Medical Inc.: Meridian Medical Inc. Expands Sales in Southern United States

[ Wed, Oct 21st 2009 ] - Market Wire

HearUSA, Inc.: HearUSA Sets Third Quarter 2009 Co .. nce Call for Tuesday, November 10 at 4:30 p.m. ET

[ Wed, Oct 21st 2009 ] - Market Wire

Metro One Development, Inc. and Imagin8: Metro On .. oyment of Two Interactive Floors in Leading Shopp

[ Wed, Oct 21st 2009 ] - Market Wire

Crucell N.V.: Crucell HIV Vaccine: Promising Prel .. Presented by Dr Dan Barouch at AIDS Vaccine 2009

[ Wed, Oct 21st 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific, Inc. Cont .. onsulting, LLC to Provide Investor Relations Serv

[ Wed, Oct 21st 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Announce .. ent in Its Phase 2 Trial of SCV-07 in Hepatitis C

Tue, October 20, 2009

[ Tue, Oct 20th 2009 ] - Market Wire

PharmaGap Inc.: PharmaGap Advises That NCI Test R .. nd Expected to Be Provided to the Company Shortly

[ Tue, Oct 20th 2009 ] - Market Wire

Baywood International, Inc.: Life Is a Whole Lot .. the Addition of New Leaf's "Sweet Tea"

[ Tue, Oct 20th 2009 ] - Market Wire

Given Imaging: Given Imaging to Host Third Quarter 2009 Financial Results Conference Calls

[ Tue, Oct 20th 2009 ] - Market Wire

Lpath, Inc.: Lpath Receives Grants From the Natio .. Publishes Key Paper in the Proceedings of the Nat

[ Tue, Oct 20th 2009 ] - Market Wire

Akela Pharma announces director resignation

[ Tue, Oct 20th 2009 ] - Market Wire

Sernova Corp.: Sernova's Cell Pouch System(TM) an .. ficacy Presented at Leading International Islet T

Mon, October 19, 2009

[ Mon, Oct 19th 2009 ] - Market Wire

BioMedReports.com: Developer Says CEL-SCI's L.E.A.P.S. Technology Has Extensive Applications

[ Mon, Oct 19th 2009 ] - Market Wire

Baywood International: Baywood International, Inc .. ands Inc., Begins Trading Under New Symbol "

[ Mon, Oct 19th 2009 ] - Market Wire

Facet Biotech Corporation: Facet Biotech's Board .. holders Continue to Reject Biogen Idec's Tender O

[ Mon, Oct 19th 2009 ] - Market Wire

AVI BioPharma, Inc.: Exon Skipping Therapy Shows .. y of Heart Disease Associated With Duchenne Muscu

[ Mon, Oct 19th 2009 ] - Market Wire

Hansen Medical, Inc.: Hansen Medical Announces Need to Restate Prior Financial Results

[ Mon, Oct 19th 2009 ] - Market Wire

&;AElig;terna Zentaris to Complete Phase 3 Clinic .. -130) as First Oral Diagnostic Test for Growth Ho

Fri, October 16, 2009

[ Fri, Oct 16th 2009 ] - Market Wire

DIAGNOS Inc.: DIAGNOS Inc.: Clarification of Prev .. usly Issued Press Release Dated October 5th, 2009

[ Fri, Oct 16th 2009 ] - Market Wire

Insulet: Insulet Corporation to Report Third Quar .. 009 Financial Results on Monday, October 26, 2009

[ Fri, Oct 16th 2009 ] - Market Wire

TomoTherapy: TomoTherapy to Announce Third-Quarter Results on Wednesday, October 28, 2009

[ Fri, Oct 16th 2009 ] - Market Wire

Cancer Therapeutics, Inc.: Cancer Therapeutics Announces Letter of Intent With NanoTherapies, LLC

[ Fri, Oct 16th 2009 ] - Market Wire

SemBioSys to be featured on CBC/Radio-Canada documentary

[ Fri, Oct 16th 2009 ] - Market Wire

Digirad: Digirad Introduces c.pax(TM) for Cardiology

Thu, October 15, 2009

[ Thu, Oct 15th 2009 ] - Market Wire

TomoTherapy: Institute Curie Hospital Purchases Second TomoTherapy(R) Radiation Therapy System

[ Thu, Oct 15th 2009 ] - Market Wire

Stellar Pharmaceuticals Inc.: Stellar Pharmaceuti .. of Positive Presentation at Major Urology Confere

[ Thu, Oct 15th 2009 ] - Market Wire

High Desert Gold Corporation: High Desert Gold An .. er of Intent with Gryphon Gold Corporation on the

[ Thu, Oct 15th 2009 ] - Market Wire

Vasogen Announces Third Quarter 2009 Results

[ Thu, Oct 15th 2009 ] - Market Wire

Radient Pharmaceuticals Corporation: Radient Phar .. Research Collaboration Agreement With CeTeCancer

[ Thu, Oct 15th 2009 ] - Market Wire

Eurand N.V.: Eurand Announces Proposed Public Offering of Ordinary Shares

Wed, October 14, 2009

[ Wed, Oct 14th 2009 ] - Market Wire

MMR Information Systems, Inc.: MMR Information Sy .. tegration of MMR PHR and MMRPro in Development Pr

[ Wed, Oct 14th 2009 ] - Market Wire

Dragon Pharmaceutical Inc.: Dragon Pharma Announces Change in Auditors

[ Wed, Oct 14th 2009 ] - Market Wire

Edwards Lifesciences : Edwards Lifesciences to Host Earnings Conference Call on October 21, 2009

[ Wed, Oct 14th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma Fills Key Animal Health and Quality Leadership Positions

[ Wed, Oct 14th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma Announces .. ing of Public Offering of 5,155,000 Common Shares

[ Wed, Oct 14th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter 2009 Results and Conduct Conference Call on

Tue, October 13, 2009

[ Tue, Oct 13th 2009 ] - Market Wire

Galapagos NV: Galapagos expands strategic alliance in metabolic disease with Merck & Co., Inc.

[ Tue, Oct 13th 2009 ] - Market Wire

Pharming Group N.V.: Pharming confirms successful closing of offer on convertible bonds

[ Tue, Oct 13th 2009 ] - Market Wire

Antisense: Antisense Therapeutics Announces ATL1103 on Track to Move Into Clinical Development

[ Tue, Oct 13th 2009 ] - Market Wire

Corcept Therapeutics: Corcept Therapeutics Announ .. ent Cash Sufficient to Fund Company Through Corlu

[ Tue, Oct 13th 2009 ] - Market Wire

Watson Pharmaceuticals, Inc.: Watson to Host Thir .. Quarter 2009 Earnings Conference Call and Webcast

[ Tue, Oct 13th 2009 ] - Market Wire

FONAR Corporation: FONAR Continues Growth With Tw .. IGHT Multi-Position MRI to U.S. Medical Practices

Mon, October 12, 2009

[ Mon, Oct 12th 2009 ] - Market Wire

San West, Inc.: San West, Inc. Declares Five-for-One Stock-Split

[ Mon, Oct 12th 2009 ] - Market Wire

iBio, Inc.: iBio to Present Advantages of Plant-B .. International Association for Biologicals Confer

[ Mon, Oct 12th 2009 ] - Market Wire

Bio-Rad Laboratories: Bio-Rad to Report Third-Qua .. 2009 Financial Results Tuesday, November 3, 2009

[ Mon, Oct 12th 2009 ] - Market Wire

TomoTherapy: TomoTherapy to Host Analyst and Inve .. tor Presentation at 2009 ASTRO Meeting in Chicago

[ Mon, Oct 12th 2009 ] - Market Wire

XTend Medical Corporation : XTend Medical (XMDC) .. cusses BioHarp Market Potential and Revenue Model

[ Mon, Oct 12th 2009 ] - Market Wire

MDRNA Inc.: MDRNA Reports UsiRNA Reduces Tumor Growth In Vivo

Fri, October 9, 2009

[ Fri, Oct 09th 2009 ] - Market Wire

San West, Inc.: San West, Inc. (SNWT) Enters Into .. nership With Second Largest Online Dealer in U.S.

[ Fri, Oct 09th 2009 ] - Market Wire

FONAR Corporation: FONAR Deemed Compliant With Al .. ng Standards; FONAR Complies With NASDAQ Marketpl

[ Fri, Oct 09th 2009 ] - Market Wire

Amarillo Biosciences, Inc.: Amarillo Biosciences .. Supporting Use of Interferon to Combat Influenza

[ Fri, Oct 09th 2009 ] - Market Wire

Horizon Health International Corp.: Retransmissio .. n Health International Corp. Announces New Symbol

[ Fri, Oct 09th 2009 ] - Market Wire

San West, Inc.: San West Inc. (SNWT) Provides His .. te Announcements, Comments on Recent Developments

[ Fri, Oct 09th 2009 ] - Market Wire

MedaSorb Technologies Corporation: MedaSorb Techn .. oration Raises $1.3M in Series B Warrant Exercise

Thu, October 8, 2009

[ Thu, Oct 08th 2009 ] - Market Wire

Edwards Lifesciences: Edwards Lifesciences to Expand Its Manufacturing and R&D Capability

[ Thu, Oct 08th 2009 ] - Market Wire

DIAGNOS Inc.: DIAGNOS Announces Memorandum of Understanding with Zeiss Canada Ltd

[ Thu, Oct 08th 2009 ] - Market Wire

ALDA Pharmaceuticals Corp.: ALDA Enters Into Supplier Agreement With Acklands-Grainger Inc.

[ Thu, Oct 08th 2009 ] - Market Wire

The Medicines Company: The Medicines Company Announces Second New Patent Issuance for Angiomax(R)

[ Thu, Oct 08th 2009 ] - Market Wire

BIOLASE Technology, Inc.: BIOLASE Wins Deloitte Tech Evolution Award

[ Thu, Oct 08th 2009 ] - Market Wire

Health This Week with Don Baillargeon; Orange Cou .. ing3, Inc.; Delgado Protocol; Francois Allyn Chef

Wed, October 7, 2009

[ Wed, Oct 07th 2009 ] - Market Wire

FONAR Corporation: NASDAQ Continues to Review FONAR's Compliance With Listing Requirements

[ Wed, Oct 07th 2009 ] - Market Wire

Amarillo Biosciences, Inc.: Amarillo Biosciences .. Intas Pharmaceuticals to Treat Influenza in India

[ Wed, Oct 07th 2009 ] - Market Wire

Baywood International, Inc.: New Leaf Joins Fight .. gainst Multiple Sclerosis in Tappan Zee Bike Ride

[ Wed, Oct 07th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces That Susquehanna Hea .. msport, PA Acquires BVA-100 Blood Volume Analyzer

[ Wed, Oct 07th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma Announces Public Offering of 4,482,609 Common Shares

[ Wed, Oct 07th 2009 ] - Market Wire

Anaconda Mining Inc.: RETRANSMISSION: Anaconda Mining Announces Changes to Its Board of Directors

Tue, October 6, 2009

[ Tue, Oct 06th 2009 ] - Market Wire

Anaconda Mining Inc.: Anaconda Mining Announces Changes to Its Board of Directors

[ Tue, Oct 06th 2009 ] - Market Wire

Vicor Technologies, Inc.: Trial Findings for Vico .. gn Diagnostic to Be Presented at the American Hea

[ Tue, Oct 06th 2009 ] - Market Wire

Micro Imaging Technology, Inc.: Micro Imaging Tec .. ing Commitment of up to $3,000,000 From Ascendian

[ Tue, Oct 06th 2009 ] - Market Wire

Midland Exploration Inc.: Midland Starts First Ex .. tion Program With Osisko on the Dunn Gold Project

[ Tue, Oct 06th 2009 ] - Market Wire

The Medicines Company: The Medicines Company Anno .. s Preliminary Third Quarter 2009 Top Line Results

[ Tue, Oct 06th 2009 ] - Market Wire

Sanguine Corporation: Sanguine Subsidiary to Chan .. From Sanguine Life Sciences to SGN Life Sciences

Mon, October 5, 2009

[ Mon, Oct 05th 2009 ] - Market Wire

FONAR Corporation: FONAR Reports Fiscal 2009 Year-End Financial Results

[ Mon, Oct 05th 2009 ] - Market Wire

ALDA Pharmaceuticals Corp.: ALDA Enters Into Vendor Agreement With London Drugs

[ Mon, Oct 05th 2009 ] - Market Wire

Eurand N.V.: Eurand Announces Conference Call on Third Quarter 2009 Financial Results

[ Mon, Oct 05th 2009 ] - Market Wire

Molecular Insight Pharmaceuticals, Inc. : Molecul .. esents Azedra(TM) 12-Month Efficacy Data From Pha

[ Mon, Oct 05th 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Receives Expan .. ment of Defense to Develop Its Drug Candidate for

[ Mon, Oct 05th 2009 ] - Market Wire

Novo Nordisk A/S: Novo Nordisk: Transaction in Own Shares

Sun, October 4, 2009

[ Sun, Oct 04th 2009 ] - Market Wire

Hansen Medical, Inc.: Hansen Medical Showcases Ne .. ated Ablation Catheter at Venice Arrhythmias 2009

Fri, October 2, 2009

[ Fri, Oct 02nd 2009 ] - Market Wire

Sierra Geothermal Power Corp.: SGP Receives Letter Requisitioning a Shareholder Meeting

[ Fri, Oct 02nd 2009 ] - Market Wire

Constellation Software Inc.: Constellation Software Announces an Increase in Credit Facility

[ Fri, Oct 02nd 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: Phase 2 Trial of .. P101 in Late-Stage Pancreatic Cancer Discontinued

[ Fri, Oct 02nd 2009 ] - Market Wire

The Medicines Company: The Medicines Company Anno .. es the Resignation of Its Chief Operating Officer

[ Fri, Oct 02nd 2009 ] - Market Wire

Omni Bio Pharmaceutical: Dr. Charles A. Dinarello .. o and Acting CEO of Omni Bio Pharmaceutical to Be

Pharming to present at Bio-Europe 2009

_{//health-fitness.news-articles.net/content/2009/10/26/pharming-to-present-at-bio-europe-2009.html}
^{Published in Health and Fitness on Monday, October 26th 2009 at 10:20 GMT by Market Wire}

LEIDEN, NETHERLANDS--(Marketwire - October 26, 2009) - Biotech company Pharming Group NV ("Pharming") (NYSE Euronext: PHARM) today announced that it will present at the 15th BIO-Europe (November 2-4, 2009) in Vienna, Austria.

Sijmen de Vries, Chief Executive Officer of Pharming, will present an update of the Company and its business at the BIO-Europe conference on Tuesday, November 3 at 11:00 am Central European Time. BIO- Europe is Europe's largest international partnering conference. The conference attendees include delegates from Europe, North America and Asia-Pacific. For further information on the BIO-Europe 2009, please visit [ http://www.ebdgroup.com/bioeurope ].

The presentation will be available on Pharming's website after the meeting.

About Pharming Group NV

Pharming Group NV is developing innovative products for the treatment of genetic disorders, ageing diseases, specialty products for surgical indications, and nutritional products. Pharming's lead product Rhucin® for acute attacks of Hereditary Angioedema has passed clinical development stage and the Market Authorization Application is under review with EMEA. Prodarsan® is in early stage clinical development for Cockayne Syndrome and lactoferrin for use in food products The advanced technologies of the Company include innovative platforms for the production of protein therapeutics, technology and processes for the purification and formulation of these products, as well as technology in the field of DNA repair (via DNage). Additional information is available on the Pharming website, [ http://www.pharming.com ].

This press release contains forward looking statements that involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company to be materially different from the results, performance or achievements expressed or implied by these forward looking statements.

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire